Blueprint Medicines (UK) Ltd is an active company incorporated on 3 July 2019 with the registered office located in London, Greater London. Blueprint Medicines (UK) Ltd was registered 6 years ago.
Termination of appointment of Georg Meyer as a director on 31 October 2025
Submitted on 31 Oct 2025
Termination of appointment of Michael David Landsittel as a director on 31 October 2025
Submitted on 31 Oct 2025
Accounts for a small company made up to 31 December 2024
Submitted on 6 Oct 2025
Cessation of Blueprint Medicines Corporation as a person with significant control on 18 July 2025
Submitted on 29 Sep 2025
Notification of Sanofi as a person with significant control on 18 July 2025
Submitted on 29 Sep 2025
Confirmation statement made on 29 June 2025 with no updates
Submitted on 30 Jun 2025
Director's details changed for Mr Timothy Andrew Jones on 1 January 2025
Submitted on 30 Jun 2025
Registered office address changed from 55 Baker Street London United Kingdom W1U 8EW England to 55 Baker Street London W1U 7EU on 14 March 2025
Submitted on 14 Mar 2025
Accounts for a small company made up to 31 December 2023
Submitted on 12 Oct 2024
Register inspection address has been changed from R+ Bdo Blagrave Street Reading United Kingdom RG1 1AZ England to Bdo Birmingham - Snowhill Two Snowhill 7th Floor Birmingham B4 6GA